Patent details

EP2558092 Title: COMBINATION COMPRISING A CYCLIN DEPENDENT KINASE 4 OR CYCLIN DEPENDENT KINASE 6 (CDK4/6) INHIBITOR AND AN MTOR INHIBITOR FOR TREATING CANCER

Basic Information

Publication number:
EP2558092
PCT Application Number:
US2011032062
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117153700
PCT Publication Number:
WO2011130232
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION COMPRISING A CYCLIN DEPENDENT KINASE 4 OR CYCLIN DEPENDENT KINASE 6 (CDK4/6) INHIBITOR AND AN MTOR INHIBITOR FOR TREATING CANCER
French Title of Invention:
COMBINAISON COMPRENANT UN INHIBITEUR DE KINASE DÉPENDANTE DE CYCLINE 4 OU DE KINASE DEPENDANTE DE CYCLINE 6 (CDK4/6) ET DE L'EVEROLIMUS POUR TRAITER LE CANCER
German Title of Invention:
KOMBINATION MIT EINEM HEMMER DER CYCLIN-ABHÄNGIGEN KINASE-4 ODER CYCLINABHÄNGIGEN KINASE-6 (CDK4/6) UND EVEROLIMUS ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
12/04/2011
Grant date:
27/06/2018
EP Publication Date:
20/02/2013
PCT Publication Date:
20/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/06/2018
EP B1 Publication Date:
27/06/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/04/2019
Expiration date:
12/04/2031
Renunciation date:
Revocation date:
24/08/2019
Annulment date:

Owner

From:
20/06/2018
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
BRAIN, Christopher Thomas
Address:
United States (US)

2

Name:
MA, Jianguo
Address:
United States (US)

3

Name:
DOSHI, Shivang
Address:
United States (US)

4

Name:
ZHANG, Hong
Address:
United States (US)

5

Name:
MURTIE, Josh
Address:
United States (US)

6

Name:
KIM, Sunkyu
Address:
United States (US)

7

Name:
BORLAND, Maria
Address:
United States (US)

Priority

Priority Number:
323541 P
Priority Date:
13/04/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/436; A61K 31/519; A61K 45/06; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
201826
Publication date:
27/06/2018
Description:
Grant (B1)

2

Issue number:
201918
Publication date:
01/05/2019
Description:
Opposition procedure started

3

Issue number:
202001
Publication date:
01/01/2020
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages